" GLP-1 "
By reducing systemic inflammation, GLP-1 may benefit individuals with chronic conditions like non-alcoholic fatty liver disease (NAFLD), rheumatoid arthritis, and even metabolic syndrome
Over the past few decades several hormones from various body systems involved in food intake have been targeted as potential treatments for obesity and diabetes, but GLP-1 seems to be the one thats risen to the top, at least for pharmacotherapy, says Scott Kanoski, a behavioral neuroscientist and professor at the University of Southern California
We support continuity of care and we do not position against a treatment you are already using
For most adults, this typically means 6-8 glasses (1.5-2 litres) of fluid daily, sipping regularly rather than consuming large volumes at once
But individual responses vary, and regular monitoring confirms your liver is responding well